Tisagenlecleucel: CAR-T Cell Therapy for B-cell Lymphoma

被引：0
|
作者：
Andres, Ulrike
机构：
来源：
TRANSFUSIONSMEDIZIN | 2019年 / 9卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T
    Crees, Zachary D.
    Ghobadi, Armin
    [J]. CANCERS, 2021, 13 (20)
  • [2] Tumor microenvironment and CAR-T cell immunotherapy in B-cell lymphoma
    Cai, Fengqing
    Zhang, Junfeng
    Gao, Hui
    Shen, Hongqiang
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 223 - 235
  • [3] Tisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
    Saha, Aditi
    Jhaveri, Khushali
    Sarfraz, Humaira
    Chavez, Julio C.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, : 869 - 876
  • [4] Tisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
    Saha, Aditi
    Jhaveri, Khushali
    Sarfraz, Humaira
    Chavez, Julio C.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023,
  • [5] The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma
    Albanyan, Omar
    Chavez, Julio
    Munoz, Javier
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [6] The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma
    Albanyan, Omar
    Chavez, Julio
    Munoz, Javier
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [7] CAR-T Cell Therapy for Lymphoma
    Ramos, Carlos A.
    Heslop, Helen E.
    Brenner, Malcolm K.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 165 - 183
  • [8] CAR T-cell therapy for B-cell lymphoma
    Denlinger, Nathan
    Bond, David
    Jaglowski, Samantha
    [J]. CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [9] CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
    Testa, Ugo
    Sica, Simona
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [10] CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
    Vairy, Stephanie
    Garcia, Julia Lopes
    Teira, Pierre
    Bittencourt, Henrique
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3885 - 3898
12345